|1.||Tsogoeva, Svetlana B: 2 articles (09/2012 - 07/2010)|
|2.||Efferth, Thomas: 2 articles (09/2012 - 07/2010)|
|3.||Anagu, Onyeka Linda: 1 article (07/2014)|
|4.||Esimone, Charles Okechukwu: 1 article (07/2014)|
|5.||Gugu, Harrison Thaddeus: 1 article (07/2014)|
|6.||Okore, Vincent Chima: 1 article (07/2014)|
|7.||Attama, Anthony Amaechi: 1 article (07/2014)|
|8.||Ngene, Augustine Arinze: 1 article (07/2014)|
|9.||Çapci, Aysun: 1 article (09/2012)|
|10.||Herrmann, Astrid: 1 article (09/2012)|
07/01/2014 - "Combination of 1000 mg/kg of NCE and 15 mg/kg of artesunic acid, produced a significant reduction of parasitemia (96.87%), compared to 20 mg/kg of artesunic acid alone (68.14%). "
06/01/2011 - "The combination of 50 mg/kg of PCE and 15 mg/kg of artesunic acid produced a significant reduction of parasitemia (81.25%), compared to 50 mg/kg PCE alone (37.7%). "
07/01/2014 - "NCE increased the activity of artesunic acid in terms of reduction in parasitemia, and increased survival time and cure rate. "
03/08/2007 - "berghei chloroquine-sensitive parasites (NK65 strain), ciprofloxacin was inactive, whereas mefloquine and artesunic acid were active (IC(50)=2.5 and 4.2 mg/kg, respectively); combinations containing mefloquine at an equivalent dose of 0.5 mg/kg reduced parasitemia by 59% and artesunic acid activity was also improved by ciprofloxacin. "
09/15/2012 - "New artesunic acid homodimers: potent reversal agents of multidrug resistance in leukemia cells."
07/08/2010 - "Cytotoxicity of artesunic acid homo- and heterodimer molecules toward sensitive and multidrug-resistant CCRF-CEM leukemia cells."
09/15/2012 - "After the successful synthesis of three artesunic acid homodimers connected by different types of chemical linkers, we analyzed their activity against human CCRF-CEM and multidrug-resistant P-glycoprotein-overexpressing CEM/ADR 5000 leukemia cells and observed, that multidrug resistant cells were not cross-resistant to the new compounds. "
07/08/2010 - "We analyzed homodimers of two artesunic acid molecules and heterohybrids of artesunic acid and betulin in human CCRF-CEM and multidrug-resistant P-glycoprotein-overexpressing CEM/ADR5000 leukemia cells. "